Selected article for: "decrease increase and time point"
Author: Kai Duan; Bende Liu; Cesheng Li; Huajun Zhang; Ting Yu; Jieming Qu; Min Zhou; Li Chen; Shengli Meng; Yong Hu; Cheng Peng; Mingchao Yuan; Jinyan Huang; Zejun Wang; Jianhong Yu; Xiaoxiao Gao; Dan Wang; Xiaoqi Yu; Li Li; Jiayou Zhang; Xiao Wu; Bei Li; Yanping Yu; Wei Chen; Yan Peng; Yeqin Hu; Lianzhen Lin; Xuefei Liu; Shihe Huang; Zhijun Zhou; Lianghao Zhang; Yue Wang; Zhi Zhang; Kun Deng; Zhiwu Xia; Qin Gong; Wei Zhang; Xiaobei Zheng; Ying Liu; Huichuan Yang; Dongbo Zhou; Ding Yu; Jifeng Hou; Zhengli Shi; Saijuan Chen; Zhu Chen; Xin-xin Zhang; Xiaoming Yang
Title: The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study
  • Document date: 2020_3_23
    • ID: 8znnq0rh_36
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03. 16.20036145 doi: medRxiv preprint receiving plasma transfusion given before 14 dpoi (patients 1, 2 and 9) in our study showed a rapid increase of lymphocyte counts and a decrease of CRP, with remarkable absorption of lung lesions in CT. Notably, patients who received CP transfusion after 14 dpoi showed much less significant improvement, .....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03. 16.20036145 doi: medRxiv preprint receiving plasma transfusion given before 14 dpoi (patients 1, 2 and 9) in our study showed a rapid increase of lymphocyte counts and a decrease of CRP, with remarkable absorption of lung lesions in CT. Notably, patients who received CP transfusion after 14 dpoi showed much less significant improvement, such as patient 10. However, the dynamics of the viremia of SARS-CoV-2 was unclear, so the optimal transfusion time point needs to be determined in the future.

    Search related documents:
    Co phrase search for related documents
    • CP transfusion and lymphocyte count: 1
    • CP transfusion and plasma transfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • CP transfusion and rapid increase: 1
    • CP transfusion and SARS viremia: 1
    • CP transfusion and transfusion time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • crp decrease and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • crp decrease and plasma transfusion: 1
    • crp decrease and significant improvement: 1, 2, 3
    • future determine and significant improvement: 1
    • lung lesion and lymphocyte count: 1, 2, 3, 4, 5, 6
    • lung lesion and significant improvement: 1, 2, 3, 4, 5, 6, 7
    • lymphocyte count and plasma transfusion: 1, 2
    • lymphocyte count and SARS viremia: 1, 2, 3
    • lymphocyte count and significant improvement: 1, 2, 3, 4, 5, 6, 7, 8
    • lymphocyte count and transfusion time: 1
    • plasma transfusion and rapid increase: 1, 2
    • plasma transfusion and significant improvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • plasma transfusion and transfusion time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • rapid increase and significant improvement: 1, 2, 3, 4